Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Correction to Company Announcement no. 37 - Notification of transactions by person discharging managerial responsibilities in Penneo

Company Announcement No. 39-2023Copenhagen, 6 December 2023On 5 December 2023 in company announcement 37, Penneo notified Finanstilsynet and publicly disclosed transactions made by a person discharging managerial responsibilities. However, in the template the prices and volumes were only disclosed as the aggregated information and not split up into seperate "Price(s)" (Section 4, c)). Hence, Penneo notifies Finanstilsynet and publicly discloses the transactions again with this amendment.  Aggregated prices and volumes remain the same.

Correction: Clarification of earlier press release today regarding Helena Hed stepping down as CEO of Projektengagemang Sweden AB

The correction pertains to a clarification that Helena Hed will continue to serve as the as CEO and President of Projektengagemang Sweden AB (Projektengagemang) until June 2024 (in the earlier press release published at 09:36, it was stated that Helena would remain as the CEO of PE Teknik & Arkitektur AB until June 2024).   The corrected press release in its entirety follows below:   After three years as CEO and President at Projektengagemang, Helena Hed has informed the company's board that she has chosen to resign from her position to pursue other opportunities. Helena will

Neonode Awarded by Leading Commercial Vehicle OEM to Supply MultiSensing® Driver Monitoring System Software

STOCKHOLM, SWEDEN, December 6, 2023 — Neonode Inc. (NASDAQ: NEON) has been awarded by a leading commercial vehicle OEM to supply Driver Monitoring System (DMS) software to the OEM’s global range of commercial vehicles. Neonode will provide a bespoke solution based on its proprietary MultiSensing platform. Neonode will receive licensing revenues from 2025 when the first vehicles equipped with Neonode's solution reach the market. The program will also generate non-recurring engineering revenues for Neonode during the coming years."We are honored and proud to have been selected as a partner to

LED iBond International A/S raise of DKK 4.5 million and issue of 12,857,144 new shares have been registered.

COMPANY ANNOUNCEMENT NO. 84LED iBond International A/S (“LED iBond”) announces that the capital raise of DKK 4.5 million has been completed. The issue of 12,857,144 new shares at a price of DKK 0.35 per share has been registered with the Danish Business Authority. As announced in Company announcement no. 81 on 29 November 2023, this is the first step in the reached agreements for DKK 10 million in new funding. Prior to the increase, the Company’s share capital amounted DKK 1,292,543.55 consisting of 25,850,871 shares of nominally DKK 0.05 each. After the nominal increase of DKK 642,857.

Skanska divests ownership of LaGuardia Terminal B in New York, USA, for USD 115M, about SEK 1.2 billion

Skanska has signed binding sale and purchase agreements (SPA) for the sale of its entire ownership, corresponding to 32 percent, of LaGuardia Gateway Partners LLC in New York, NY, USA, for USD 115M, about SEK 1.2 billion. The buyers are existing partners MI LaGuardia CTB, LLC and Vantage Airport Group (New York) LLC. The transaction is expected to be recorded during the fourth quarter of 2023 and will be allocated to the Central stream.Completion of the sale is conditional on regulatory approval and customary terms and conditions. The final purchase price may be adjusted by transaction

FlexQube receives AMR-order worth 500 000 USD

FlexQube has received its first order for the new and patented FlexQube Navigator AMR (autonomous mobile robot) system in the Nordic market. The order value is about 500 000 USD, and the customer is a global producer of commercial vehicles. The customer is located in Sweden, and delivery is planned to be completed during Q2 2024.  Mårten Frostne, CEO at FlexQube comments: “It is fantastic to see the first order for our new AMR system in the Nordic market to one of the market leaders within the commercial vehicles market. We look forward to delivering a great solution and to continue

Gaming Innovation Group issues new EUR/SEK dual tranche senior secured bonds

Reference is made to the press release dated 27 November 2023 regarding a contemplated bond issue.  Gaming Innovation Group Plc., a wholly owned subsidiary of Gaming Innovation Group Inc., has successfully completed the issuance of new 3-year EUR 75 million equivalent senior secured bonds, split in a EUR 45m and a SEK 350m tranche, and with a combined borrowing limit of EUR 100m equivalent. The net proceeds will be used to call the existing SEK 550 million bond with ISIN: NO0011017097 in full (including call premium), partly finance the acquisition of KaFe Rocks and for general corporate

Diamyd Medical's Precision Medicine patent for the prevention and treatment of autoimmune diabetes granted in South Korea

The patent, granted by the South Korean Patent Office and valid until 2035, safeguards the application of GAD autoantigen in treating or preventing autoimmune diabetes, specifically in individuals with the HLA DR3-DQ2 gene. GAD, the key component in Diamyd[®], an antigen-specific immunotherapy, currently under evaluation in the registrational Phase III trial DIAGNODE-3. This trial is recruiting patients with recent-onset Type 1 Diabetes across eight European countries and the US.HLA DR3-DQ2 is a genetic marker linked to Type 1 Diabetes, found in up to 40% of those with the disease. The

Medivir publishes prospectus in connection with the rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD REQUIRE ADDITIONAL PROSPECTUS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE IS UNLAWFUL OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH ACTION. REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS

Monica Holmvik Persdotter is Vattenfall´s new Vice President Brand

Vattenfall has appointed Monica Holmvik Persdotter as new Vice President and Head of Brand. Monica is a senior brand and marketing executive, at present leading the global brand and sustainability communication at Arla Foods, the fifth largest dairy company in the world. She will join Vattenfall in March 2024.“I´m very pleased to welcome Monica to Vattenfall and to our team. She brings a broad international experience of working with strongly profiled brands, being highly commercial while also grasping the societal context that is so important to us in the energy sector. Her combination of

ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msek

ODI Pharma AB (“ODI” or the “Company”) announces today the sale of the skincare brand kandol. to Niclas Kappelin. The transaction, valued at 3.2 million SEK, includes the transfer of all inventories, production materials, trademarks, and copyrights associated with kandol. In connection with the transaction, CEO Derek Simmross and Chairman of the Board Volker Wiederrich will transfer 2,300,000 and 200,000 shares, off market, respectively to the buyer as part of the transaction.ODI announces that the Company has sold the skincare brand kandol. to the main shareholder Niclas Kappelin for 3.2

PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry

6 December 2023   PanGenomic Health Inc. (“PanGenomic” or the “Company”)   PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry   Vancouver, British Columbia, Canada, 6 December 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has introduced its point-of-care Vitamin D test for the dental implant industry.   "Vitamin D can play a significant role in the success of a dental implant

American Industrial Partners Capital Fund VII to Acquire Veoneer’s Restraint Control Systems Business

Stockholm and New York, December 6, 2023: The automotive technology company Veoneer today announced that it has entered into an agreement with an investment fund managed by American Industrial Partners (“AIP”), for the acquisition of Veoneer’s Restraint Control Systems business from SSW Partners LP (“SSW”).The transaction with American Industrial Partners Capital Fund VII (“AIP Fund VII”) completes Veoneer’s and SSW’s strategy of finding the right long-term homes for Veoneer’s three original lines of business: Arriver™ Software, now owned by Qualcomm; Active Safety, now owned by Magna

Generative AI Video Producer Waymark and Self-Serve Adtech Provider DanAds automate entire TV Advertising Journey

Collaboration enables media platforms to offer instant ad creation, targeted media planning and buyingDETROIT, MI and STOCKHOLM, Sweden – Waymark , an AI video creation technology company, and DanAds , a provider of self-serve advertising automation technology, today announce a partnership that provides global publishers and media owners with a fully automated, white-labeled self-serve advertising infrastructure, offering comprehensive AI-generated creative production, transparent targeting and immediate distribution for their customers. A

Wetteri Plc updates its communication policy

Wetteri Plc  Stock Exchange Release   December 6, 2023 at 14.00 EETWetteri Oyj updates its communication policy regarding the official communication language. Wetter's official reporting languages are Finnish and English. All official material is published in both Finnish and English. The dominant language is Finnish in case of possible differences in interpretation. For further information: Aarne Simula, CEO, Wetteri Oyj Tel. +358 400 689 613, aarne.simula@wetteri.fi Panu Kauppinen, CFO, Wetteri Oyj Tel. +358 44 236 3740, panu.kauppinen@wetteri.fi Wetteri Plc – an

Observe Medical – First order to Croatia

Oslo, December 6, 2023 - Observe Medical (the “Company" or "Observe Medical") has received first order for delivery of UnoMeter 500 and Abdo Pressure products from our distributor in Croatia, Stoma Medical.   The UnoMeter portfolio is experiencing rapid expansion, having recently secured orders from Croatia, bringing the total count to 17 countries. The favorable clinical evaluations contribute positively to the reputation of our UnoMeter products, demonstrating confidence in their continued success across diverse markets. Jørgen Mann, Chief Commercial Officer at Observe Medical,

Notice of Extraordinary General Meeting in MyFirstApp Sweden AB (publ)

The shareholders of MyFirstApp Sweden AB (publ), corp. ID 556670-3038, are hereby invited to an extraordinary general meeting on January 11, 2024, at 09:00 AM at Birger Jarlsgatan 20, 5th floor, 114 34 Stockholm.Shareholders who wish to participate in the meeting must be entered in the printout of the share register regarding the conditions on January 3, 2024, and must notify the company of their attendance no later than January 8, 2024, in writing to BOX 164 16, 103 27 Stockholm, or by email to jesper@myfirstapp.com. The notification should include the name, personal or organization

Medivir’s partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its partner, IGM Biosciences, has communicated a strategic pipeline prioritization and reduction of workforce with the key aim of extending its cash runway in a challenging financial climate.   In the announcement by IGM, a number of its programs are impacted by this pipeline prioritization, including the combination of IGM’s DR-5 agonist, aplitabart and birinapant, which IGM licensed from

OM Pharma appoints Roch Ogier as Chief Executive Officer

OM Pharma, a global biopharmaceutical company headquartered in Switzerland, announced the appointment of Roch Ogier as Chief Executive Officer (CEO), effective January 1, 2024. He will succeed Josef Troxler, who will continue to share his expertise as Senior Advisor and Chairman of the Board of the Swiss Affiliate.Geneva, Switzerland, 6 December 2023 - OM Pharma’s Board of Directors has appointed Roch Ogier as Chief Executive Officer (CEO) with effect from January 1, 2024. Roch, currently Chief Operating Officer, brings a wealth of experience in the biotechnology field and across the

Important portfolio updates from Katalysen Ventures with aggregated positive impact on portfolio value

Today, Katalysen Ventures AB (publ) (“Katalysen”) announced important portfolio updates, with a total positive impact on the estimated total portfolio value of +10.7 MSEK (+6.7%) since last communicated portfolio value.Katalysen has decided to conduct a write-down, with a negative impact on book value of -13.6 MSEK, resulting in a -12.3 MSEK impact on Katalysen’s estimated portfolio value. This adjustment is attributable to the portfolio ventures VenturePort, Payer, and Uggla. Furthermore, Katalysen recently announced the inaugural investment of Venture Targeter AB (“Venture Targeter”),

Business Update from M.O.B.A. Network - Positive Download Trend and Development

MOBA Network proudly announces that the company's efforts over the past quarters have resulted in significant progress. With a focus on continuing to develop our platforms, we can report that Porofessor, one of our acquired platforms, has seen a substantial increase in the number of downloads since its acquisition. Porofessor has reached a total of 11.5 million downloads, with a steady growth rate of over 7,800 per day. Additionally, we observe a positive trend in revenue per user. In addition to the development of Porofessor's user base, we have been actively working on structuring and

There are no items matching the current filter
There are no more items matching the current filter
Back to top